The ability of injured axons to regenerate declines with age, yet the mechanisms that regulate axon regeneration in response to age are not known. Here we show that axon regeneration in aging C. elegans motor neurons is inhibited by the conserved insulin/IGF1 receptor DAF-2. DAF-2's function in regeneration is mediated by intrinsic neuronal activity of the forkhead transcription factor DAF-16/FOXO. DAF-16 regulates regeneration independently of lifespan, indicating that neuronal aging is an intrinsic, neuron-specific, and genetically regulated process. In addition, we found that DAF-18/ PTEN inhibits regeneration independently of age and FOXO signaling via the TOR pathway. Finally, DLK-1, a conserved regulator of regeneration, is downregulated by insulin/IGF1 signaling, bound by DAF-16 in neurons, and required for both DAF-16-and DAF-18-mediated regeneration. Together, our data establish that insulin signaling specifically inhibits regeneration in aging adult neurons and that this mechanism is independent of PTEN and TOR.
INTRODUCTION
Axon regeneration has the potential to repair damaged neurons in response to injury. However, across species, the regenerative potential of injured neurons decreases with age. For example, in the mammalian peripheral nervous system, where regeneration does occur in adults, regenerative potential is lower in old animals (Pestronk et al., 1980; Tanaka et al., 1992; Verdú et al., 1995 Verdú et al., , 2000 . In C. elegans, axon regeneration also declines during adulthood (Gabel et al., 2008; Hammarlund et al., 2009; Nix et al., 2011; Wu et al., 2007; Zou et al., 2013) . In animals with a mature nervous system, the various effects of age on axon regeneration could be a secondary consequence of aging's deleterious effects on the organism as a whole or a result of interactions between neurons and an aging cellular environment. Alternatively, the effects of age could be part of a specific program executed in neurons. Understanding the mechanisms that regulate the decline of regeneration with age could help inform therapies for age-related changes in neuronal function, disease, and recovery. However, the mechanisms that mediate the decline of regeneration in adults are not well understood.
To characterize a neuron's response to age and injury, we investigated age-related decline in axon regeneration in C. elegans. C. elegans is a leading genetic model of aging (Antebi, 2007; Kenyon, 2010) . Moreover, C. elegans has a wellcharacterized, invariant nervous system and has recently emerged as a model for neuronal aging (White et al., 1986; Pan et al., 2011; Tank et al., 2011; Toth et al., 2012) . Finally, C. elegans is a powerful system for studying axon regeneration (Chen and Chisholm, 2011; El Bejjani and Hammarlund, 2012) . Individual postdevelopmental C. elegans axons are readily amenable to pulsed laser axotomy, and their regeneration is easily visualized in vivo (Byrne et al., 2011; Gabel et al., 2008; Hammarlund et al., 2009; Rao et al., 2008; Wu et al., 2007; Yanik et al., 2004) . Thus, the worm holds the potential to identify mechanisms that regulate how age alters the response of neurons to injury.
Here we analyze how age affects regeneration in the GABA motor neurons of adult C. elegans. We show that as adult animals age, these neurons exhibit decreased retraction, decreased growth response, and decreased extension in response to nerve injury. We show that this decline in regeneration is regulated by the insulin/IGF1 receptor daf-2 and the forkhead transcription factor daf-16/FOXO. daf-16 functions cell intrinsically in neurons to regulate regeneration independently of daf-16's function in lifespan determination. The conserved phosphatase daf-18/protein phosphatase and tensin homolog (PTEN) (deleted on chromosome 10) also regulates regeneration yet does so in an age-and insulin-independent manner, via target of rapamycin (TOR) signaling. Moreover, regeneration in both daf-2 and daf-18 mutants requires the critical dlk-1/DLK plasticity pathway. Our findings demonstrate that age-related decline in adult axon regeneration is an intrinsic, neuron-specific, and genetically regulated process and define separable functions for the INSR/IGF1R-FOXO and the PTEN-TOR pathways in regulating axon regeneration an aged animals.
RESULTS

Insulin/IGF1 Signaling Inhibits Axon Regeneration and Does so Specifically in Aged Animals
We investigated the relationship between axon regeneration and age using single-neuron pulsed-laser surgery in adult C. elegans GABA motor neurons ( Figure 1A ). To address the effects of adult age (rather than developmental changes) on regeneration, we compared regeneration of severed axons at two adult time points: 1-day adults, aged 1 day past the final larval stage (young adults) and 5-day adults, aged 5 days past the final larval stage (aged adults). These adult time points occur well after the GABA neurons complete development by forming functional synaptic connections onto their final postsynaptic targets-a process that is finished by the second of four larval stages that precede adulthood in the C. elegans life cycle (Wood, 1988) . We found that in young adult wild-type animals, 65% of axons regenerated in response to injury ( Figures 1B and 1D ), consistent with previous reports (Hammarlund et al., 2009) . By contrast, in aged adult wild-type animals, few axons (28%) initiated a regeneration response to injury ( Figures 1C and 1D) . Therefore, axon regeneration declines in adulthood, in large part due to failure in aged animals of growth cone initiation in response to nerve injury.
Axon regeneration is a complex, multistep process in which the injured neuron must respond to injury by initiating a growth cone and then sustain axon extension toward the appropriate target. To characterize the effect of age on regeneration, we binned cut axons into four categories based on how far they had regenerated toward their target, the dorsal nerve cord ( Figures 1A-1D ). We found that in aged animals, even axons that did regenerate in response to injury were defective at extension toward the target. Of the severed axons that did regenerate in aged adult wild-type animals, only 12% made substantial progress toward the dorsal nerve cord (Figure 1E; MLÀ and ML versus ML+ and Full) . By contrast, in young adult animals, 31% of regenerating axons made substantial progress toward the dorsal nerve cord after 24 hr ( Figure 1E ). Thus, of the few axons that do regenerate in aged adult animals, 88% fail to extend toward their targets in the dorsal nerve cord. Therefore, both axon initiation and extension after nerve injury are inhibited in aged adult animals relative to young adult animals. Together, these deficiencies result in an overall failure of axon regeneration in 5-day wildtype adults, in stark contrast to the robust axon regeneration observed in wild-type adults that are 4 days younger.
We hypothesized that the age-related decline in GABA axon regeneration might be suppressed by manipulations that delay aging and increase lifespan. We tested axon regeneration in several well-characterized models that increase lifespan, including animals that have decreased insulin signaling (daf-2 mutants) (Kenyon et al., 1993; Kimura et al., 1997) , animals that overexpress sirtuin and have an additional lifespanincreasing mutation (sir-2.1OE mutants) (Tissenbaum and Guarente, 2001; Viswanathan and Guarente, 2011) , and animals that are calorically restricted as a result of eating difficulty (eat-2 mutants) (Avery, 1993; Lakowski and Hekimi, 1998) . Of these models, neither sir-2.1 nor eat-2 significantly affected regeneration (p > 0.3; Fisher's exact test). However, modification of insulin signaling by mutating the insulin/insulin-like growth factor 1 receptor (INSR/IGF1R) DAF-2 enhanced regeneration in aged adults. We found that in contrast to wild-type animals, 5-day adult daf-2(À) mutants exhibited no decline in axon regeneration (Figures 2A and 2B ). daf-2 regulates regeneration specifically in aged animals, as the frequency of regeneration in young adult daf-2(À) mutants was indistinguishable from that in young adult wild-type animals ( Figure 2D ). Therefore, daf-2 specifically regulates an age-related decline in axon regeneration.
We characterized the specific effects of daf-2 on age-related regeneration using the same categorical analysis as described above (Figures 2A and 2C) . In contrast to aged wild-type animals, only 30% of axons in aged daf-2(À) mutants failed to respond to injury. Therefore, daf-2 inhibits growth cone initiation in aged axons. Furthermore, in contrast to the 12% of wild-type axons that made substantial progress toward the dorsal nerve cord in wild-type animals, approximately 48% of regenerating axons made considerable progress toward, or reached, the dorsal nerve cord in daf-2(À) mutants ( Figure 2C ; ML+ and Full). These results indicate that daf-2 inhibits both growth cone initiation and axon growth in aged animals.
To confirm that the failure of axons in aged wild-type animals to regenerate past the midline is due to defects in growth and not inaccurate axon guidance, we measured the length of severed axons. We found that 24 hr after being cut, axons were significantly longer in daf-2(À) mutants than in wild-type animals ( Figure 2E ). Interestingly, retraction after injury was also affected by daf-2. After axotomy in young animals, the injured ends of the axon retract away from the cut site (Hammarlund et al., 2009) . We found that this retraction was reduced or absent in aged wild-type animals ( Figure 2E ). The average length of the distal (dorsal) commissural fragments of injured axons in aged wildtype animals extended just ventral of the midline, consistent with a lack of retraction away from the cut site (Figures 2A and  2E ). By contrast, we observed axon retraction in the distal (dorsal) commissural fragments of injured axons in aged daf-2(À) animals (Figures 2A and 2E) . Further, the average length of the distal (dorsal) commissural fragments of injured axons in these animals did not reach the midline, consistent with retraction away from the cut site (Figures 2A and 2C) . Together, these results suggest that axon retraction is compromised in aged animals-possibly due to a lack of elasticity-and show that this defect is rescued in daf-2(À) animals. Further, these results show that the increased regeneration we observe in aged daf-2(À) animals is not because the daf-2(À) axons retract less: in fact, daf-2(À) axons retract more and also regenerate farther. Therefore, daf-2 regulates growth rather than guidance of regenerating axons.
Although lack of daf-2 extended the ability of wild-type animals to regenerate, it did not do so indefinitely. The frequency of axon regeneration in daf-2(À) mutants declined by 10 days postdevelopment ( Figure 2D ). However, even in these old animals, some degree of axon regeneration was still present in daf-2(À) animals. By contrast, in wild-type animals 10 days postdevelopment, regeneration was never observed ( Figure 2D ). In summary, our results demonstrate that the INS/IGF1 receptor DAF-2 regulates both growth cone initiation and axon extension in aged adult animals after injury. (B) Quantification of regeneration in 5-day adult wild-type and daf-2(e1370) animals 24 hr after axotomy. Regeneration in 5-day adult daf-2(À) animals is significantly increased relative to 5-day adult wild-type animals (p < 0.01; Fisher's exact test). (C) Regenerating axons were binned into categories according to how far they extended toward the dorsal nerve cord (categories described in Figure 1 ). More severed axons in aged adult daf-2(À) animals extend significantly (ML+ and Full) compared to severed axons in aged adult wildtype animals (p < 0.01; Fisher's exact test). (D) Axon regeneration frequencies in wild-type and daf-2(e1370) animals of increasing age. (E) Lengths of commissural fragments 24 hr after axotomy in 5-day adults. Width represents commissure length prior to axotomy. For precision, axons were severed on the ventral side of the seam cells, which are located at the midline. All animals express the Punc-47::GFP reporter. Error bars represent 95% confidence intervals in (B) and (D) and standard error in (E).
DAF-2 Regulates Regeneration in Aged Animals via DAF-16/FOXO daf-2/INSR/IGF1R
regulates lifespan by activating mechanisms that sequester the forkhead transcription factor daf-16/FOXO in the cytoplasm, thus preventing daf-16/FOXO from translocating to the nucleus and regulating transcription of effector genes (Henderson and Johnson, 2001; Kenyon et al., 1993; Lee et al., 2001; Lin et al., 2001) . Mutations that disrupt daf-2/INSR/ IGF1R result in a 2-fold increase in lifespan that is dependent on daf-16/FOXO (Kenyon et al., 1993) . To test whether inhibition of regeneration by daf-2 also functions by inhibiting daf-16, we assessed regeneration in mutants that lacked both daf-2 and daf-16. We found that eliminating daf-16 in daf-2(À) mutants abolished the high regeneration normally observed in aged daf-2(À) mutants (Figures 3A and 3B) . By contrast, axons in aged animals lacking only daf-16 regenerated similarly to wildtype axons (Figures 3A and 3B) , consistent with the finding that daf-16/FOXO activity is mostly inhibited in wild-type animals (Lin et al., 2001 ). Therefore, daf-2 inhibits regeneration in aged animals by preventing daf-16 function.
DAF-16/FOXO Regulates Regeneration Independently of Its Role in Lifespan Determination
The effects we observed of daf-2 and daf-16 on axon regeneration correlate with their effects on lifespan ( Figures 3A and 3C ). daf-2(À) mutants live longer, and their axons regenerate well when aged; animals lacking both daf-2 and daf-16 do not live longer, and their axons do not regenerate well when aged. One possible model to explain this finding is that increased axon regeneration in 5-day adult daf-2(À) mutants is a secondary consequence of delayed aging ( Figure 3D , hatched arrow ii). However, not all manipulations that affect lifespan also affect axon regeneration (see sir-2.1 and eat-2, above), as would be expected if the decline in axon regeneration were secondary to senectitude. Further, the steep decline in regeneration that we observe in 5-day-aged wild-type adults occurs well before significant age-related mortality ( Figure 3C ). Even at 10 days, when both wild-type animals and daf-2 mutants have lost all or most regenerative ability ( Figure 2D ), mortality is limited ( Figure 3C ). Together, these data suggest that senectitude and loss of regenerative ability are separable phenomena but that both are regulated by daf-2 and daf-16 ( Figure 3D , hatched arrow i).
To test the idea that age-related loss of axon regeneration and lifespan are separately regulated, we attempted to decouple the two phenotypes using daf-16(À) mosaic animals ( Figure 4 ). Although daf-16/FOXO is required for lifespan extension in daf-2/INSR/IGF1R mutants, restoring daf-16 to the intestine of daf-2(À); daf-16(À) double mutants (intestine::daf-16*) is sufficient to increase their lifespan (Libina et al., 2003) . We reasoned that if daf-16 function in neurons-rather than daf-16 function in lifespan extension-is required to increase regeneration in aged animals, the intestine::daf-16* animals should fail to regenerate when aged, even though they have increased lifespans. We found that intestine::daf-16* animals did exhibit increased lifespan compared to controls, consistent with previous results (Libina et al., 2003) (Figures 4A and 4B , +Pges-1:daf-16; Figure S1 available online). However, 5-day adult intestine:: daf-16* animals showed a low level of axon regeneration that was similar to wild-type ( Figures 4C and 4D) . Thus, despite increasing the lifespan of daf-2(À); daf-16(À) double mutants, intestinal DAF-16 expression did not affect age-related decline of regeneration (Figures 4B and 4C, . We conclude that daf-16 and insulin/IGF1 signaling can regulate lifespan independently of regeneration and that increased lifespan is not sufficient to increase axon regeneration in aged animals.
These results suggested that daf-16 might function in neurons to increase regeneration in aged animals. Indeed, the growth potential of injured axons depends in part on intrinsic factors (Neumann et al., 2002; Neumann and Woolf, 1999; Qiu et al., 2002) . Thus, daf-16/FOXO could regulate axon regeneration by acting directly in neurons. If so, we reasoned that neuron-specific daf-16 expression might rescue age-related regeneration in a daf-2(À); daf-16(À) background. We expressed wild-type daf-16 under the control of the pan-neuronal promoter Prgef-1 in daf-2(À); daf-16(À) mutants (neuron:daf-16*). In these animals, daf-16 is expressed only in neurons, where it is active due to the lack of daf-2. Neuronal-specific expression of daf-16 had no effect on lifespan (Figures 4A and 4B, . However, aged neuron:daf-16* animals had improved axon regeneration compared to controls, even though they did not live any longer (Figures 4B and 4C, . These results show that daf-16 function in neurons is sufficient to regulate axon regeneration.
Although neuron-specific expression of daf-16 improved axon regeneration in aged daf-2(À); daf-16(À) mutants, it was not as robust as axon regeneration in aged daf-2(À) mutants (compare Figures 3B and 4D ). This partial rescue may simply be the result of differences in neuronal expression of daf-16 between the endogenous locus and the Prgef-1-driven transgene. Alternatively, it may be an indication that while neuronal daf-16 is necessary and sufficient to promote regeneration, robust regeneration also requires daf-16 function outside the nervous system. Indeed, daf-16 has recently been shown to promote developmental neuronal migration (Christensen et al., 2011; Kennedy et al., 2013) . Together, our data demonstrate that age-related decline of regeneration is not a secondary consequence of lifespan-related aging and define a new function for daf-16 in regulating axon regeneration cell-autonomously in the aging nervous system.
DAF-18/PTEN Inhibits Regeneration Independently of Age and DAF-16/FOXO
Like daf-16/FOXO, daf-18/PTEN (protein phosphatase and tensin homolog deleted on chromosome 10) is required for lifespan extension in daf-2/INSR/IFG1R mutants (Dorman et al., 1995; Larsen et al., 1995) . However, unlike daf-16, which positively regulates regeneration in daf-2(À) mutants ( Figure 3A) , PTEN inhibits axon regeneration in mice and flies (Christie et al., 2010; Liu et al., 2010; Park et al., 2008; Song et al., 2012b; Sun et al., 2011) . To determine the role of PTEN in axon regeneration in C. elegans, we assessed regeneration in young and aged adult daf-18/PTEN mutants. We found that like loss of daf-2, loss of daf-18/PTEN significantly increased regeneration in aged adults ( Figures 2B and 5B) . However, unlike daf-2 (which had no effect on young animals), loss of daf-18/PTEN also increased regeneration in young adults ( Figures 2D and  5A ). The increase in regeneration in aged daf-18/PTEN mutants was not as large as that seen in aged daf-2 mutants ( Figures  5B and 2B) , and regenerating axons in aged daf-18/PTEN mutants often had a less robust growth structure ( Figures 5D  and 2C ). Nonetheless, these data indicate that PTEN's role as an inhibitor of axon regeneration is conserved in C. elegans.
Although loss of daf-18/PTEN and daf-2/INSR/IGF1R both result in increased regeneration in aged adults, the two mutations have different effects on lifespan. Loss of daf-2/INSR/ IGF1R increases lifespan, and this increase depends on daf-16/FOXO activation (Henderson and Johnson, 2001; Kenyon et al., 1993; Lee et al., 2001; Lin et al., 2001) . By contrast, loss of daf-18/PTEN decreases lifespan and can suppress both 
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Insulin/IGF1 Inhibits Regeneration in Aged Animals extended lifespan and daf-16 activation in daf-2 mutants (Dorman et al., 1995; Larsen et al., 1995; Masse et al., 2005; Ogg and Ruvkun, 1998) (Figure 5E ). Since daf-18/PTEN mutants have shorter lives than wild-type animals (Dorman et al., 1995; Larsen et al., 1995) (Figure 5E ) but retain the ability to regenerate axons when aged ( Figure 5B ), the loss of PTEN is another way (besides daf-16 mosaics-see Figure 4 ) to decouple lifespan and axon regeneration in aged animals. Further, the finding that daf-18 and daf-2 both increase regeneration despite having opposite effects on lifespan suggests that they may regulate axon regeneration by different mechanisms.
To determine whether enhanced regeneration in daf-18/PTEN is due to the same mechanism as enhanced regeneration in daf-2 mutants, we determined its dependence on daf-16. In contrast to daf-2 mutants, which increase regeneration (and lifespan) in a daf-16-dependent manner (Kenyon et al., 1993) , we found that axon regeneration in PTEN mutants was independent of daf-16. In aged adults, axons in animals that lacked both daf-18 and daf-16 (daf-18(mg150); daf-16(mu86)) regenerated as frequently as axons in daf-18(mg150) animals ( Figure 5B ). This lack of interaction between daf-18/PTEN and daf-16/FOXO in regulating axon regeneration was also observed in animals that lacked daf-2/INSR/IFG1R: we observed no difference in axon regeneration between aged daf-2(e1370); daf-18(mg198) and aged daf-2(e1370); daf-18(mg198); daf-16(mu86) animals ( Figure 5F ). In addition, we found that GABA-specific daf-18 expression (driven by the unc-47 [vesicular GABA transporter] promoter) inhibits regeneration in aged daf-18(À) mutants ( Figure 5G ). Therefore, daf-18 functions cell intrinsically to inhibit axon regeneration, independently of insulin signaling and FOXO.
Another important output of PTEN activity is inhibition of the TOR pathway (Song et al., 2012a) . Mutation of PTEN results in increased AKT activity, leading to increased phosphorylation and reduced activity of the TSC complex (Maehama and Dixon, 1998; Song et al., 2012a; Stambolic et al., 1998; Sun et al., 1999) . In turn, reduced TSC activity results in increased signaling by TOR (Manning and Cantley, 2003) . We investigated whether increased TOR activity might account for the effect of loss of PTEN on axon regeneration in aged C. elegans GABA neurons. We inhibited TOR with rapamycin and found that had no effect on control animals, suggesting that TOR signaling is not a major component of axon regeneration in aged wild-type animals. By contrast, rapamycin treatment abolished the increased axon regeneration phenotype of daf-18/PTEN mutants ( Figure 6 ). These results suggest that daf-18/PTEN's function in regeneration is mediated by TOR in C. elegans. TOR has previously been shown to mediate the effect of PTEN on axon regeneration in mammals (Christie et al., 2010; Liu et al., 2010; Park et al., 2008; Song et al., 2012b; Sun et al., 2011) . Thus, the PTEN-TOR axis represents a conserved mechanism that regulates axon regeneration across species.
Next, we tested whether activated TOR might also mediate the effect of loss of DAF-2 on axon regeneration in aged animals. We found that regeneration in aged daf-2(e1370) mutants is not affected by rapamycin (Figure 6 ). Therefore daf-2/ INSR/IGF1R functions independently of TOR to regulate regeneration, in contrast to daf-18/PTEN. These findings strengthen our conclusion that, despite functioning in the same pathway to regulate lifespan, DAF-18/PTEN and insulin signaling function independently of one another to regulate axon regeneration: DAF-18/PTEN signaling functions via regulation of TOR and insulin signaling functions via regulation of DAF-16 activity.
DLK-1 Is Required for DAF-2-and DAF-18-Mediated Regeneration
The strong and cell-autonomous regulation of regeneration by the transcription factor daf-16/FOXO suggests that transcriptional regulation of one or more neuronal genes accounts for the DAF-16-dependent increase in axon regeneration we observe in aged daf-2(À) mutants. One potential target of such regulation is the genes of the dlk-1 MAP kinase pathwaythe best-characterized intrinsic regeneration pathway in C. elegans. dlk-1/DLK-1 is a conserved dual-leucine zipper kinase MAPKKK that functions in axon regeneration by activating mkk-4/MAPKK and pmk-3/MAPK (Hammarlund et al., 2009; Nakata et al., 2005; Yan et al., 2009 ). Activated pmk-3/MAPK promotes regeneration at least in part by posttranscriptional stabilization of the mRNA for the B-Zip protein cebp-1/C/EBP1, likely via mak-2/MAPKAP2 (Yan et al., 2009 ). dlk-1 is also negatively regulated by the E3 ubiquitin ligase rpm-1/PHR1 (Hammarlund et al., 2009; Nakata et al., 2005; Yan et al., 2009 ). DLK-1 pathway function is required cell autonomously to regulate regeneration across species (Hammarlund et al., 2009; Itoh et al., 2009; Shin et al., 2012; Watkins et al., 2013; Xiong et al., 2010) . Overexpression of dlk-1 in GABA neurons confers an increase in regenerative potential to both young and aged animals (Hammarlund et al., 2009) , without increasing lifespan ( Figure S2) . Therefore, the dlk-1 MAP kinase pathway is a candidate target for daf-16-mediated regulation of age-related regeneration.
To investigate whether dlk-1 functions with daf-16 to regulate regeneration, we first performed genetic epistasis experiments between dlk-1 and daf-16 ( Figure 7A ). We found that dlk-1 is absolutely required for regeneration in aged daf-2(À), and aged daf-18(À) mutants ( Figure 7A ) (Hammarlund et al., 2009) . In addition, dlk-1 overexpression was sufficient to rescue regeneration in daf-16 mutants. Since dlk-1 is also absolutely necessary and sufficient for regeneration in aged wild-type animals, these results indicate that dlk-1 functions downstream or in parallel to daf-16 and daf-18. To test whether the dlk-1 MAP kinase pathway is regulated in an age-dependent manner by daf-16, we compared the expression levels of dlk-1 pathway genes in aged wild-type and daf-2(À) mutants (in which daf-16 function is elevated) using quantitative RT-PCR. We found that in aged daf-2(À) mutants, expression of three dlk-1 pathway genes were specifically increased compared to wild-type: dlk-1, mak-2, and cebp-1 ( Figures 7B and S2) . The increase we observe in cebp-1 expression may be a secondary consequence of dlk-1 upregulation, since dlk-1 activity increases cebp-1 mRNA levels by mak-2-mediated posttranscriptional stabilization (Yan et al., 2009) .
Next, we asked whether daf-16 directly regulates one or more dlk-1 pathway components. To do so, we examined data from two independent methods-chromatin immunoprecipitation sequencing (ChIP-seq) and DNA adenine methyltransferase identification (DamID)-that identified physical interactions between DAF-16 and the genome. We found that, uniquely among dlk-1 pathway genes, DAF-16 physically interacts with dlk-1 by both ChIP-seq and DamID (Celniker et al., 2009; Schuster et al., 2010) . Further, the physical interaction between DAF-16 and the dlk-1 promoter region is partially organized around canonical DAF-16 binding sites. Together, these findings indicate that DAF-16 binds to dlk-1 and may regulate its activity.
With respect to regeneration, DAF-16 functions specifically in the nervous system (Figure 4) . We used tissue-specific ChIP-seq data to investigate whether DAF-16 binds directly to dlk-1 in neurons ( Figures 7C-7F ). Single-copy integration techniques (Frøkjaer-Jensen et al., 2012) were used to make transgenes that expressed GFP-tagged DAF-16A under either a neuronal (rgef-1) or an intestinal (spl-1) promoter. Integrated transgenes were placed in a background of daf-2 mutation (to activate nuclear translocation of the GFP-tagged DAF-16) and daf-16 mutation (to avoid competition from untagged DAF-16). An anti-GFP antibody was used to perform ChIP-seq from each of the two resulting strains. Two replicates each of neuronal and intestinal DAF-16A-bound DNA were sequenced and analyzed. Overall, the analysis identified 1,526 DAF-16 binding sites in neurons and 6,525 binding sites in intestine (unpublished data; Figures 7E and 7F) . Consistent with previous results, the canonical DAF-16 binding element (TGTTTAC; Murphy et al., 2003) was significantly overrepresented in the 500 most enriched sequences in both tissues (e values are 1.3 3 10 À14 for neurons and 1.6 3 10 À43 for intestine) (Bailey et al., 2009 ).
Analysis of the ChIP-seq data demonstrated that DAF-16 binds the dlk-1 promoter directly in neurons ( Figure 7F ). DAF-16 also binds dlk-1 in the intestine. However, the binding profiles at the dlk-1 locus differ in neurons and in the intestine ( Figure 7F ). In neurons, DAF-16 bound two peaks. In the intestine, DAF-16 bound three peaks, one of which was also bound by DAF-16 in neurons. Together with the evidence that daf-16 functions cell autonomously in neurons to regulate regeneration (Figure 4 ) and that dlk-1 expression is regulated in an age-and daf-16-dependent manner ( Figures 7B and S2) , these results suggest that one effect of DAF-16 activity in aged animals is to increase expression of dlk-1 in neurons.
Together, our data demonstrate that one notable difference between aged wild-type and daf-2(À) animals is expression of dlk-1 pathway genes and suggest that increased dlk-1 pathway activity in neurons-perhaps due to binding and direct regulation of dlk-1 by neuronal DAF-16-contributes to high regeneration in aged daf-2 animals.
DISCUSSION INSR/IGFR1 and FOXO Function Independently of PTEN and TOR to Regulate Axon Regeneration in Aged Neurons
Axon regeneration in adult C. elegans declines dramatically with age. In this study, we show that this decline is not a secondary consequence of organismal aging but is an intrinsic property of aging neurons themselves. We identify two independent neuronal mechanisms that regulate axon regeneration in the GABA neurons of aged animals: activity of the transcription factor DAF-16/FOXO, potentially via the dlk-1/DLK regeneration pathway, and activity of the lipid phosphatase DAF-18/PTEN, via regulation of TOR.
DAF-16 Protects an Aging Nervous System
Our results show that the insulin signaling pathway acts in aged animals to inhibit regeneration via regulation of daf-16 activity in the nervous system. In the absence of insulin signaling, increased daf-16 activity allows the neuron to regenerate in response to injury. Recently, insulin signaling and daf-16 were also shown to regulate the maintenance of neuronal morphology in aging animals. The mechanosensory neurons (as well as some other neuronal types) accumulate aberrant branches and other morphological defects in an age-dependent manner, and accumulation of defects is delayed in daf-2(À) mutant animals, which have increased DAF-16 activity (Pan et al., 2011; Tank et al., 2011; Toth et al., 2012) . Together, these data suggest that insulin signaling and DAF-16/FOXO regulate multiple protective processes in aging neurons, including the ability to regenerate in response to injury and the ability to maintain axon morphology.
The functions of DAF-16 in aging neurons are likely complex. Activated daf-16 enhances regenerative growth after laser injury ( Figure 3A ) but suppresses aberrant growth in neurons that have not received an external injury (Pan et al., 2011; Tank et al., 2011; Toth et al., 2012) . Further, regeneration in aged animals is dependent on the dlk-1 MAP kinase pathway (Figure 7) , while aberrant growth is independent of the dlk-1 pathway (Tank et al., 2011) . Finally, although in aged animals both axon regeneration and maintenance of morphology are both regulated by insulin signaling and daf-16, the effects of aging occur at different rates. We found that insulin signaling acts at an early stage of adult life-between 1 and 5 days-to inhibit daf-16 and reduce regeneration of GABA neurons, with regeneration declining 10-fold in this time period ( Figure 2D ). By contrast, the accumulation of morphological defects in uninjured GABA neurons is much slower: no defects are observed at 8 days (Toth et al., 2012) , and even at 10 days of adult life, not all animals have accumulated GABA neuron defects (Tank et al., 2011) . Together, these data suggest that DAF-16 has multiple independent protective functions in aging neurons.
Conserved Regeneration Mechanisms in C. elegans PTEN and TOR also regulate GABA axon regeneration. In mutant animals that lack daf-18/PTEN, an increase in TOR activity results in increased regeneration ( Figure 6 ). Like daf-16/FOXO, the effect of PTEN and TOR on axon regeneration is intrinsic to the nervous system ( Figure 5G) . However, the effect of PTEN and TOR on axon regeneration differs from that of daf-16/ FOXO in that daf-18/PTEN regulates axon regeneration in both young and aged adult animals ( Figures 5A and 5B ). In mice, PTEN disruption promotes axon regeneration of retinal ganglion cells (Park et al., 2008) , peripheral sensory (sciatic) neurons (Christie et al., 2010) , and corticospinal neurons (Liu et al., 2010) . Further, at least in the CNS, the full effect of PTEN deletion on axon regeneration requires mTOR activation (Liu et al., 2010; Park et al., 2008) . In Drosophila, disrupting PTEN promotes axon regeneration of the class IV dendritic arborization (da) neurons (Song et al., 2012b) . Thus, PTEN and TOR signaling have emerged as major conserved regulators of axon regeneration, and increasing TOR activity may be useful for improving regeneration, particularly in combination with other proregenerative manipulations (Sun et al., 2011) .
Our data establish C. elegans as a new model for studying the function of PTEN, TOR, and FOXO in axon regeneration. The conservation of PTEN and TOR functions in axon regeneration-along with conservation of the DLK-1 pathway (Hammarlund et al., 2009; Itoh et al., 2009; Shin et al., 2012; Watkins et al., 2013; Xiong et al., 2010; Yan et al., 2009) , calcium signaling (Ghosh-Roy et al., 2010; Pichichero et al., 1973; Spencer and Filbin, 2004; Ziv and Spira, 1997) , and microtubule stability (Ghosh-Roy et al., 2012; Hellal et al., 2011; Sengottuvel et al., 2011) -suggests that axon regeneration itself, and the intrinsic molecular mechanisms that regulate it, are of ancient origin and are functionally conserved across highly divergent species.
Both DAF-16/FOXO and TOR have multiple downstream effectors and are global regulators of cellular function. TOR signaling regulates multiple functions via one of two complexes, TORC1 or TORC2. These functions include nutrient sensing, cell growth, actin organization, cytoskeletal dynamics, autophagy, and stress response (Guertin and Sabatini, 2007) . DAF-16/ FOXO is a transcription factor that, when activated-as in daf-2(À) mutants-regulates the expression of a large number of target genes (Kenyon et al., 1993; Murphy et al., 2003; Schuster et al., 2010; Oh et al., 2006) . DAF-16's many functions include metabolism, lifespan, synapse maintenance, and axon morphology (Murphy, 2006; Pan et al., 2011; Tank et al., 2011; Toth et al., 2012) . Our data suggest that one important output of insulin-FOXO signaling is upregulation of the conserved dlk-1 regeneration pathway. Further studies will be necessary to identify other functions of insulin-FOXO signaling in aging neurons and to determine the downstream effectors of PTEN-TOR.
Lifespan and Neuronal Healthspan Are Independent Phenotypes
In addition to identifying molecular mechanisms that regulate GABA neuron regeneration in aging animals, our results demonstrate that the regulation of neuronal repair in aging animals is an essential component of healthspan, as opposed to lifespan. In other words, aging and loss of plasticity in neurons is an autonomous process that does not depend on overall lifespan. First, DAF-2/INSR/IGF1R inhibits axon regeneration in older animals by modulating neuronal DAF-16/FOXO function, and this function is independent of lifespan. Second, despite functioning antagonistically to regulate lifespan (Dorman et al., 1995) , both loss of daf-18/PTEN and loss of daf-2 result in increased regeneration. Moreover, lifespan and healthspan are distinct at the cellular level, as DAF-16/FOXO functions in intestinal cells to regulate lifespan (Libina et al., 2003) and in neurons to regulate regeneration. Therefore, our results demonstrate that agerelated decline in axon regeneration can be decoupled from lifespan, and these two effects of time are functionally distinct. The very early decline of regenerative potential suggests that the mechanisms described here may modulate a critical inflection point on the downward curve of neuronal function.
EXPERIMENTAL PROCEDURES Axotomy Experiments
Axotomy experiments were carried out as previously described (Byrne et al., 2011) . Postaxotomy images were acquired with an Olympus DSU mounted on an Olympus BX61 microscope, Andor Neo sCMOS camera, and Lumen light source. Error bars represent 95% confidence intervals. Significance is indicated with an asterisk (p < 0.01; Fisher's exact test). Lengths of regenerating axons were measured with MetaMorph software.
Lifespan Analysis
Lifespans were carried out as previously described (Apfeld (Kaeberlein et al., 2005) . Animals were plated as L4s (t = 0) and grown at 25 C. Animals that crawled off of the plate or ruptured were censored.
Survival curves were generated with GraphPad Prism. Significance was determined with the log rank (Mantel-Cox) test. n values were greater than 55 for each condition tested.
Quantitative RT-PCR
To perform quantitative RT-PCR, total RNA was extracted from 100-worm samples of N2 or CB1370 with TRIzol and QIAGEN RNeasy. cDNA was made from 100 ng of total RNA with AffinityScript Multiple Temperature cDNA synthesis kit. qPCR was performed with Power SYBR green from Applied Biosystems and cycled on an Applied Biosystems 7,500 Fast system. All reactions were repeated multiple times: three technical replicates for each of two biological replicates were performed. No-reverse transcriptase and notemplate controls were included in each experiment. Two to three endogenous controls were included in each experiment, and all data was normalized to ama-1. Error bars represent 95% confidence intervals.
Rapamycin
Worms were grown on rapamycin at a previously reported effective concentration for C. elegans culture (Robida-Stubbs et al., 2012) .
Chromatin Immunoprecipitation-Deep Sequencing ChIP-seq was performed essentially as described in Zhong et al. (2010) for two technical replicates of each strain analyzed, with the following modifications. Synchronized populations of worms were grown on peptone-enriched plates seeded with OP50 and were collected at the L4 stage. Worms were fixed in 2% formaldehyde in M9 buffer for 30 min at room temperature. Worm pellets were sonicated to prepare protein lysate containing chromatin sheared between 100-1000 bp using a Sonic Dismembrator (Fisher). Immunoprecipitation was completed using 2 mg of protein lysate and 7.5 mg a-GFP (Zhong et al., 2010) at 4 C overnight. One tenth of a fraction of lysate was used to prepare an input DNA sample. Library preparation of XE1464 DNA samples for ChIP-seq was completed essentially as described in Zhong et al. (2010) . XE1464 input and ChIP DNA samples were size selected to enrich for DNA ranging from 180-400 bp. Libraries prepared from all XE1464 DNA samples were multiplexed as described in Lefranç ois et al. (2009) and were sequenced using the Illumina GA2 sequencing platform. Library preparation of XE1593 input and ChIP DNA samples for ChIP-seq was completed using the Ovation Multiplex Library System (NuGEN), in which additional size selection was not performed. Libraries prepared from XE1593 DNA samples were sequenced using the Illumina HiSeq 2000 sequencing platform.
Following sequencing, all samples were uniformly processed using parameters established by the modENCODE consortium for the mapping of transcription factor binding sites (C.L. Araya, personal communication; Trinh et al., 2013) . Significantly enriched peaks were called using SPP and IDR analysis tools (Trinh et al., 2013) . Gene annotations for the C. elegans genome were compiled from several sources and mapped to genome build WS220. Coding gene models were collected from Wormbase WS235 and the C. elegans mod-ENCODE project, which includes the analysis of many RNA-seq data sets to develop aggregated and improved gene models. Similarly, noncoding RNA gene models were collected from the C. elegans modENCODE project, Lu et al. (2011) , and Wormbase WS235 (for tRNAs, snoRNAs, snRNAs, miRNAs, 21U-RNAs, etc). Candidate target gene models were assigned based on closest proximity to the highest point of the binding site, irrespective of whether the binding site is upstream or downstream of the 5 0 or 3 0 end of the gene (21U-RNAs were excluded from this assignment). In addition, nearby gene models (both coding and noncoding) are listed but not assigned as the candidate target gene.
Strains
Strains (detailed in Supplemental Experimental Procedures) were maintained as previously described at 20 C (Brenner, 1974 
